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Background: To evaluate feasibility and potential effectiveness of a patient decision aid (PtDA) for patients and a
preference report for surgeons to reduce wait times and improve decision quality in patients with osteoarthritis
considering total knee replacement.
Methods: A prospective two-arm pilot randomized controlled trial. Patients with osteoarthritis were eligible if they
understood English and were referred for surgical consultation about an initial total knee arthroplasty at a Canadian
orthopaedic joint assessment clinic. Patients were randomized to the PtDA intervention or usual education. The
intervention was an osteoarthritis PtDA for patients and a one-page preference report summarizing patients’ clinical
and decisional data for their surgeon. The main feasibility outcomes were rates of recruitment and questionnaire
completion; the preliminary effectiveness outcomes were wait times and decision quality.
Results: Of 180 patients eligible for surgical consultation, 142 (79%) were recruited and randomized to the PtDA
intervention (n = 71) or usual education (n = 71). Data collection yielded a 93% questionnaire completion rate
with less than 1% missing items. After one year, 13% of patients remained on the surgical wait list. The median
time from referral to being off the wait list (censored using survival analysis techniques) was 33.4 weeks for the
PtDA group (n = 69, 95% CI: 26.0, 41.4) and 33.0 weeks for usual education (n = 71, 95% CI: 26.1, 39.9). Patients
exposed to the PtDA had higher decision quality based on knowledge (71% versus 47%; p < 0.0001) and quality
decision being an informed choice that is consistent with their values for option outcomes (56.4% versus 25.0%;
p < 0.001).
Conclusions: Recruitment of patients with osteoarthritis considering surgery and data collection were feasible.
As some patients remained on the surgical waiting list after one year, follow-up should be extended to two
years. Patients exposed to the PtDA achieved higher decision quality compared to those receiving usual
education but there was no difference in wait for surgery.
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Osteoarthritis is a common, disabling, and costly disease.
Optimal medical management of osteoarthritis includes
both non-pharmacologic and pharmacologic interventions
[1]. For advanced disease, if medical therapy has failed, total
joint arthroplasty (TJA) of the hip and knee is cost-effective
[2-4]. However, referral for TJA is increasing due to an aging
population. Wait times for surgery – both time to surgical
consultation and to surgery once a decision is made to
proceed - are unacceptably long in Canada [5-7]. Improving
access while decreasing wait times for TJA is a priority for
enhancing efficiency of care and patient satisfaction.
Previous efforts to reduce wait times for TJA have fo-
cused on the waiting period to undergo surgery, after the
decision to proceed with a TJA is made with the surgeon.
Such strategies include centralized waitlist management,
triage, establishing maximum wait time benchmarks, in-
creasing surgical capacity, and optimizing care pathways
[5,8-11]. An important additional approach is to assess the
patient’s informed preferences, prior to surgical consult-
ation. In doing this, unnecessary referrals for surgical con-
sultation may be avoided [12]. For instance, surgical
candidates who never intend to have surgery would be
identified prior to referral, thus decreasing the wait list
[13-15]. Given that patient preferences for TJA are associ-
ated with their perceptions of the risks and benefits of the
procedure, discussing risks and benefits when eliciting pa-
tient preferences can also ensure that those wanting sur-
gery can access the proper pathways [15-20].
Unwillingness to consider TJA as a treatment option has
been linked to misperceptions about the indications for,
and risks and benefits of, TJA [15,16,21]. Patient prefer-
ences and perceptions about treatment options may be ad-
dressed using a patient decision aid (PtDA). PtDAs help
patients become involved in health decisions by making the
decision explicit, providing information about the options
and their risks and benefits, and clarifying patients’ values.
PtDAs are intended to be used in conjunction with regular
consultation. A Cochrane review of 115 randomized con-
trolled trials (RCT) showed that PtDAs increase patient
participation in decision making, improve knowledge and
realistic perceptions of benefits and harms, reduce deci-
sional conflict, and improve the match between the chosen
option and informed patients’ values [22]. PtDAs can have
a substantive effect on over- and under-use of elective
surgeries. In regions with high rates of surgical procedures
(e.g., hysterectomy, discectomy, prostatectomy, coronary
bypass surgery), PtDAs reduced preferences for surgical
procedures by 20% without affecting health outcomes or
patient satisfaction [22]. In regions where surgical rates
were very low (e.g., prostatectomy in UK with shortage of
urologists), the surgery rates increased. As such, PtDAs
may have a role in ensuring that wait list reforms address
under-use of surgical procedures that informed patientsneed and want, while preventing the over-use of procedures
that informed patients do not value.
Two recent studies evaluated a PtDA focused on osteo-
arthritis with surgery and non-surgery options [23,24].
This PtDA is a booklet and DVD with high quality ratings
based on the International Patient Decision Aid Standards
[25]. Findings in one randomized controlled trial (RCT)
revealed that compared to controls (n = 62) patients who
used this PtDA (n = 61) felt more informed and confident
in what to ask their doctor; the surgeons reported greater
satisfaction and efficiency with the consultation and indi-
cated that patients exposed to the PtDA asked more ap-
propriate questions [23]. The other trial showed lower
decisional conflict in those exposed to the PtDA (n = 70)
compared to the PtDA with an adaptive conjoint analysis
(n = 69) or educational booklet (n = 69) [24].
The objectives of this pilot RCT were to evaluate feasi-
bility and to provide preliminary data on the effectiveness
of the PtDA with a preference report for surgeons on wait
times and decision quality in patients with osteoarthritis
considering total knee replacement.
Methods
Design
A two-arm prospective RCT was conducted. Study ap-
proval was received from The Ottawa Hospital Research
Ethics Board (# 2006724-01H) and the trial was regis-
tered (ClinicalTrials.gov, NCT00743951).
Setting
Patients with osteoarthritis of the knee were recruited from
an orthopaedic intake clinic, within a Canadian tertiary
hospital. The sports medicine physician assessed surgical
eligibility using the 7-item Western Wait List Hip Knee Pri-
ority Tool (HKPT) [8] mapped onto the three criteria for
total knee arthroplasty according to the clinical practice
guidelines (moderate to severe pain, moderate to severe
functional limitations, and abnormal radiographic findings)
[1]. Although, the priority tool was originally developed and
validated as a transparent and fair approach for prioritizing
patients on waitlists, it is used in this clinical setting as a
standardized assessment tool applied to all patients. From
April 2006 to March 2007, 47% of patients at this clinic
were assessed to have milder osteoarthritis and were di-
rected back to their referring physician with suggestions for
conservative management [12]. The others were deemed
eligible for surgical consideration for knee osteoarthritis.
Participants
Eligible knee osteoarthritis patients were those with ac-
cess to a television with a VCR or DVD player. Those
with inflammatory arthritis, previous TJA, uncorrected
hearing or visual impairment, or unable to read, or
understand English, were excluded.
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Experimental group
The PtDA, developed by the Informed Medical Decisions
Foundation and distributed through Health Dialog, is enti-
tled Treatment Choices for Knee Osteoarthritis. It consists
of a 50-minute video and accompanying booklet that pro-
vides information on various treatment options for knee
osteoarthritis, including lifestyle changes, non-drug treat-
ments, pain medication, injections, complementary therap-
ies, and surgery. A description of the options, probabilities
of benefits and harms for each option, and video-clips of
patient experiences allows patients to clarify their values as-
sociated with outcomes of options. According to the Inter-
national Patient Decision Aid Standards, this PtDA meets
most criteria for content (12 of 15), development process
(8 of 9), and effectiveness (1 of 2). For more details on the
IPDAS score card and the PtDA go to: http://decisionaid.
ohri.ca/AZsumm.php?ID=1191. Patients received a ques-
tionnaire, formatted as user-friendly booklet, assessing their
knowledge, values, preferred treatment choice, decisional
conflict, and comments or questions. These results were
combined with the patients’ clinical assessment findings
to create a one-page preference report for the surgeon (see
Figure 1) [26].
Control group
Patients in the usual education group received a standard
information booklet prepared by the participating hospital
for all patients undergoing joint replacement surgery. In-
formation included preparation for surgery, recovery after
surgery, and discharge plans. There was no information
on benefits and harms of surgery or alterative options that
could be used for decision making. Surgeons for patients
in the control group received a half-page summary of pa-
tients’ clinical assessment findings only.
Procedures
Eligible patients met with a research assistant who col-
lected consent to participate in the study and baseline
data. Baseline data included the Western Ontario
McMaster Universities Osteoarthritis Index (WOMAC)
measuring the patient’s perceptions of knee pain, stiff-
ness and function, the HKPT completed by the assessing
physician, and demographic information. This data was
used to populate the surgeon’s clinical summary report
(upper half of Figure 1).
After baseline data collection, patients were allocated to
the PtDA intervention or usual education. The allocation
schedule was computer-generated centrally by a statistician
using a permuted block design with randomly varying block
lengths of 4, 6, or 8. Allocations were concealed in num-
bered opaque sealed envelopes until after signed consent
was obtained. Once allocated, patients were instructed to
review their respective information (i.e., PtDA plus usualeducation booklet or usual education booklet only) at home
and complete the accompanying questionnaire. Patients
were not informed of the intervention characteristics. Al-
though the research assistant was not blinded to group allo-
cation, study outcomes for effectiveness were objective and
obtained from clinic data (e.g. date of surgery or waitlist
status).
Within two weeks from recruitment, the research assist-
ant telephoned participants to obtain their answers to the
questionnaire. This information was added to the surgeon’s
clinical summary report to create the surgeon preference
report (Figure 1). Participants were contacted by telephone
one year after recruitment to determine whether they had
seen the orthopaedic surgeon, and if so, whether they had
chosen surgery or alternative non-surgical options. Dates
for surgeon consultation and surgery were collected from
the hospital health information system.
Outcomes
The main feasibility outcomes were recruitment and ques-
tionnaire completion rates [27]. Feasibility targets were:
a) >70% study enrollment of eligible patients; b) >90% of
patients completing questionnaires at home prior to sur-
geon consultation; and c) <10% missing data. Preliminary
effectiveness outcomes were wait times, decision quality,
preparation for decision making, decisional conflict and
patient feedback on the PtDA.
Preliminary effectiveness outcomes were assessed to in-
form a future larger scale RCT. Wait times were calcu-
lated based on the number of days from screening to
definitive choices (i.e., date of surgery or date of decision
to decline the surgery either explicitly stated or based on
date appointment was cancelled without rebooking). Deci-
sion quality was defined as the extent to which patients’
decisions were informed and values congruent with their
choice. Decision quality was deemed sufficient if a patient
scored ≥66% on the knowledge test and if their predicted
probability of surgery based on values corresponded with
their actual choice. A score of 66% was chosen because
the mean score for patients who had completed the know-
ledge test after viewing the PtDA was 68% [28] and it is
consistent with knowledge scores in trials of PtDAs [22].
Outcome measurement instruments
Hip-Knee Osteoarthritis Decision Quality Instrument
Patients’ knowledge was assessed using four multiple choice
questions (i.e., osteoarthritis progress over time, need for
revision joint replacement, proportion of patients with re-
duced pain, and length of time for recovery) from the Hip-
Knee Osteoarthritis Decision Quality Instrument [28].
Knowledge scores were previously shown to be reprodu-
cible and to discriminate between those exposed to PtDAs
and controls [28]. Patients’ values were measured by asking
patients to rate the personal importance of the benefits and
Figure 1 Summary report for surgeons [26].
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point rating scale with 1 indicating low importance and 10
indicating high importance. In a previous study, those who
valued pain relief and return to normal activities were more
likely to choose surgery while those who valued surgery
avoidance were less likely to choose surgery [28]. The valid-
ity of these items have previously been demonstrated: pa-
tients whose treatment choice was concordant with their
values felt more confident and had less regret with their de-
cision [28].
Decisional Conflict Scale
The SURE tool, a 4-item version of the Decisional Conflict
Scale, was used to assess patients’ perception of feeling sure,
informed, supported, and clear about what mattered most
[29]. In patients considering treatment options, this tool
was previously shown to have adequate internal consistency
with Kuder-Richardson 20 coefficient of 0.7 and significant
correlation between the Decisional Conflict Scale and
SURE scores [1].
Preparation for Decision Making
Four of the 10 items on the Preparation for Decision
Making Scale [30] were used to determine patients’ per-
ceptions of the decision making process. Four items
were chosen because of their relevance to surgical deci-
sions and they discriminated between patients prepared
for decision making with PtDAs and those who were
not. The items include recognition that a decision needs
to be made (discrimination value 2.12), knowledge that
the best choice depends on what matters most to the pa-
tient (3.39), level of decision making involvement desired
by the patient (2.61), and patient preparedness for dis-
cussion with the surgeon (3.08). This instrument reports
good internal consistency (>0.91) and excellent item dis-
crimination (range 2.12 – 3.80) [30].
Data management & statistical analysis
All data were entered twice into Microsoft Excel, verified
for accuracy, and analyzed using SAS v. 9.1. Feasibility out-
comes were summarized using descriptive statistics. Di-
chotomous effectiveness outcomes were describing using
proportions with 95% confidence intervals and differences
between arms were tested for statistical significance using
chi-squared tests. Differences in the between groups me-
dian wait list times were described using Kaplan-Meier sur-
vival curves with 95% confidence intervals and were
assessed for statistical significance using the log-rank test.
Patients were censored at the end of the study, at the time
of death, or loss to follow-up.
The mean scores on the knowledge test (calculated as
the percentage of correct answers) were compared be-
tween the two groups using the two-sample t-test. The
match between the patients’ choice and their values forbenefits/risks was calculated as a dichotomous measure.
The predicted probability of surgery was calculated for
each patient using a logistic regression equation derived
from three items assessing the patient’s values. The equa-
tion was [1 + exp (–S)]–1 where S = -0.3384 + 0.3869 ×
Value Q6 – 0.6111 ×Value Q7 + 0.1933 ×Value Q8 (Q6
relieve pain; Q7 avoid surgery; Q8 return to usual activ-
ities). The predicted probabilities were rounded to 0 or 1
(0 = no surgery and 1 = surgery) to determine the pre-
dicted choice based on the patient’s values. Mean scores
on the Decisional Conflict Scale and Preparation for Deci-
sion Making scale were compared using the two-sample t-
test. All tests were carried out at the two-sided 5% level of




Of the180 patients deemed appropriate for surgical consult-
ation between February 2007 and April 2008, 142 (78.9%)
were eligible and consented to participate (see Figure 2).
The most common reason for ineligibility was inadequate
English. Of those eligible, 71 were randomized to the PtDA
intervention group, 71 to usual education group. Sixty-six
patients in both groups (93%) completed the question-
naires after exposure to the PtDA intervention and/or
usual education materials. For those who completed the
questionnaires, there was less than 1% missing responses
for individual items. Two participants from the PtDA
intervention group withdrew from the study and three
participants from the usual education group were lost to
follow-up. When supplemented with data from the hos-
pital health information system, data on 140 (98.6%) pa-
tients was used for analysis of wait times.
Patient demographic characteristics indicate that the
typical participant was 67 years of age, female, retired, and
had completed secondary school (see Table 1). There were
no statistically significant baseline differences between the
groups based on demographic characteristics, WOMAC
scores, or HKPT scores.
Overall, patients’ feedback about the PtDA was positive.
Patients liked using the PtDA as a tool to communicate
and share with others. Patient 40 said that the PtDA “…
helped my spouse to understand what I was going through”.
Comments indicated that patients liked the presentation
and some said it helped them arrive at a decision. For in-
stance, Patient 101 reported, “…the information regarding
total knee replacement was very good” and Patient 97 indi-
cated, “This material was very helpful. It helped me to de-
cide that of all the options available, knee replacement
surgery is the best option in my case.” Patients said the
PtDA helped them learn the facts and have their questions
answered. For example, Patient 117 said “…the video clari-
fied the points that I had questions on” and Patient 96
Assessed for eligibility (n= 180)
Analysed  (n= 69)
(2 withdrew and were excluded from
analysis)
Allocated to intervention (n= 71)
and 71 patients received PtDA
Allocated to usual education (n= 71)
and received it



























questionnaires  (n= 66)
Completed post-
intervention 
questionnaires  (n= 66)
Figure 2 CONSORT trial flow diagram.
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tape very good.” Finally, the PtDA helped patients under-
stand that they had a role in decision making, which was
supported by Patient 126’s comment, “Excellent tool that
really helped me understand the importance of my collab-
orative decision making with the health care team.”
Ten patients provided negative feedback. Some wanted
more information about “…the wait time, the recoveryTable 1 Patient demographic characteristics
PtDA intervention Usual education
(n = 69) (n = 68)
Age (yrs), mean (SD) 67.1 (10.85) 67.3 (12.16)
HKPT* (total 80), mean (SD) 43.9 (12.4) 45.1 (17.5)
WOMAC* (total 96), mean (SD) 60 (0.17) 64 (0.18)
Men 19 (27.5%) 25 (35.2%)
Women 50 (72.5%) 46 (64.8%)
Education
Less than secondary school 10 (14.5%) 12 (16.9%)
Secondary school/trades school 25 (36.2%) 30 (42.3%)
Post-secondary education 32 (36.4%) 24 (33.8%)
Missing 2 (2.9%) 5 (7.0%)
Retired 37 (53.6%) 42 (59.1%)
*higher scores indicate higher severity of osteoarthritis.time, and the consequences” (Patient 98). Information
that was described as confusing included when “people
were talking about personal stories” (Patient 21), and
“pictures on the first page” (Patient 24).
At the end of the 1-year follow-up period (May 2009),
55 of 69 patients in the PtDA group had undergone sur-
gery (79.7%; 95% CI 70.2 to 89.2%), 5 chose non-surgical
management, 8 were still on the waiting list for surgery,
and 1 had died. Of 68 patients in the usual education
group, 48 underwent surgery (70.6%; 95% CI 59.8 to
81.4%), 9 chose non-surgical management, 10 were still on
the waiting list for surgery, and 1 had died. There was no
statistically significant difference between groups in the
proportions of patients undergoing surgery (difference be-
tween PtDA versus usual education 9.1%, 95% CI -5.3% to
23.5%, p = 0.2165).
Preliminary effectiveness outcomes
The median total wait times from the screening consult-
ation to a definitive decision (e.g. underwent surgery or
off wait list for non-surgical management) was 33.4
weeks for the PtDA group (n = 69, 95% CI: 26.0, 41.4)
compared to 33.0 weeks for the usual education group
(n = 71, 95% CI: 26.1, 39.9) (see Figure 3). There was no
significant difference in the time on the wait list between
groups (log-rank p = 0.6622).
Figure 3 Wait times (screening to definitive decision) by group.
Stacey et al. BMC Musculoskeletal Disorders 2014, 15:54 Page 7 of 10
http://www.biomedcentral.com/1471-2474/15/54Mean knowledge scores for patients who used the PtDA
were 71.2% compared to 46.6% in the usual education
group (p < 0.01) (see Table 2). Patients in the PtDA group
were more likely to have a higher quality decision
(informed choice that matched their values for outcomes
of options) (31 of 55 (56.4%) versus 14 of 56 (25.0%); p <
0.001). After exposure to the intervention and prior to the
surgeon consultation, 20 of 66 patients in the PtDA group
(30.3%) were unsure of the best option (prefer surgery or
prefer non-surgery) compared to 9 of 66 patients in the
usual education group (13.6%) (p = 0.0208). There were no
statistically significant differences between groups for any
items on the Decisional Conflict Scale or Preparation for
Decision Making scale.
Discussion
Feasibility and considerations for subsequent trial
Our study showed that it was feasible to recruit patients
with knee osteoarthritis, administer the decision support
interventions, and collect outcome measures. Patients in
this study rated their experience using the PtDA favor-
ably as indicated in both the preparation for decision
making items and their qualitative feedback.
Surgical wait times were challenging to measure given
the length of time patients wait for surgery in Canada. As
reported earlier, 12% of patients in the PtDA group and
15% of patients in the usual education group were still
waiting for surgery after one year. This suggests that using
the reported Canadian averages to determine the durationof the study is not adequate for collecting follow-up mea-
sures. In fact, patients need to be followed for much lon-
ger to ensure accurate comparisons between groups.
Whether or not wait times is an appropriate primary
outcome for a subsequent study must be considered. This
study was originally designed to recruit patients prior to
attending the surgical screening clinic but was changed
during the ethics approval process to recruit patients in
the clinic. Interestingly, almost half the patients assessed
in this screening clinic were sent back to the referring
physician because they were diagnosed with milder osteo-
arthritis and ineligible for this study [12]. Given that the
PtDA included information on non-surgical management
options for osteoarthritis and the significant improvement
in knowledge among patients exposed to the PtDA, it may
be more appropriate to recruit patients with various sever-
ity of osteoarthritis to the study instead of limiting recruit-
ment to those eligible for surgical consultation.
Preliminary effectiveness
Measuring decision quality as a composite measure was
possible in this study. A quality decision, the ultimate
goal of PtDAs, is ideally measured by using patient’s
score on the knowledge test as an indicator of being in-
formed, and measuring the concordance between the
informed patient’s values for outcomes of options and
the actual choice of surgery (or non-surgery) [25,31]. In
this study, patients exposed to the PtDA intervention
obtained significantly higher decision quality (56%)
Table 2 Preliminary effectiveness outcomes
PtDA Usual education
Knowledge, mean n = 66 n = 66
71.2% 46.6%
High quality decision, n (%) n = 55 n = 56
31 (56.4) 14 (25.0)
Uptake of chosen option at one year, n (%) n = 69 n = 68
TJA surgery 55 (79.7) 48 (70.6)
No surgery 5 (7.2) 9 (13.2)
Waiting list 8 (11.6) 10 (14.7)
Died 1 (1.4) 1 (1.5)
Median total wait time from screening consultation to definitive decision n = 69 n = 71
33.4 weeks 33.0 weeks
SURE test scores* prior to surgeon consultation, n (%) n = 65 n = 66
Feels SURE about best choice 47 (72.3) 53 (80.3)
Knows the benefits and harm of each option 60 (92.3) 44 (66.7)
Clear about which benefits and risks matter most 57 (87.7) 49 (74.2)
Has enough support and advice to make choice 50 (76.9) 51 (77.3)
TOTAL SURE score = 4 45 (69.2) 38 (57.6)
Preparation for decision making†, mean (SD) n = 66 n = 64
Help recognize decision to be made 4.121 (1.209) 3.781 (1.253)
Help know decision depends on what matters most 4.477 (0.850) 4.141 (1.096)
Help think about how involved you want to be in decision 4.477 (0.812) 4.250 (1.054)
Prepare you to talk to your doctor about what matters most 4.364 (0.905) 4.234 (1.035)
*Those not responding YES are experiencing decisional conflict.
†scored on a 5-point scale from 1 (not at all) to 5 (a great deal).
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These findings are consistent with a systematic review
of 115 trials of PtDAs that showed a 51% higher im-
provement in informed values-based choices [22]. How-
ever, several trials included in the systematic review
used ‘feeling clear about values’ rather than the actual
measure of values-choice concordance.
Patients in the PtDA intervention group who had learned
more about their options, benefits and harms reported
more decisional conflict about their decision prior to con-
sultation with the surgeon compared to the usual education
group. Although we didn’t reassess decisional conflict after
surgical consultation, there was no statistically significant
difference between groups in the proportion of patients in-
dicating they were unsure about the best option. The higher
level of decisional conflict in patients exposed to PtDAs
prior to surgical consultation is consistent with findings in
a study of women with breast cancer considering surgical
options [32]. Women considering options for breast cancer
surgery had improved knowledge, better clarity of values
and felt more supported, but were only sure of the best op-
tion after consultation with the surgeon. Patients need to
discuss their values and preferences with the surgeon priorto feeling certain about the best treatment choice for them.
Furthermore, PtDAs encouraged patients to use informa-
tion on options including relevant benefits and harms when
making a treatment choice [33], and as observed in this
study achieving a higher quality choice. By helping patients
achieve a higher quality decision and ensuring a positive de-
cision making experience, they are more likely to avoid
downstream decisional regret [34].
Limitations
There are three main limitations to consider when inter-
preting the results of this study. In terms of designing a fu-
ture trial, patients need to be followed for longer given
that 13% were still waiting for surgery after one year.
Using the results from the pilot study, the required sample
size for a future definitive trial can be determined: 155 pa-
tients per group, followed over two years, would be re-
quired to detect a clinically important difference of 8
weeks in mean total wait times, using a two-sided t-test at
the 5% level of significance with 80% power, assuming a
common standard deviation of 25 weeks. To account for
10% loss to follow-up, we would need to enroll 173 pa-
tients per group. Also, decisional conflict and preferred
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Given that a quarter of patients in the PtDA group felt un-
sure, a subsequent study should also measure decisional
conflict after seeing the surgeon. Limitations related to
the preliminary effectiveness outcomes are potential
for self-report bias given that most outcome measures
were patient reported. For the outcome of actual
choice, self-report bias may have been mitigated be-
cause data was also extracted from the patients’ health
record for verification of the data.
Conclusions
This pilot RCT demonstrated a high patient recruitment
rate and completed patient questionnaires with minimal
missing data. Therefore, the feasibility targets were met,
warranting future larger scale trial. Preliminary effectiveness
outcomes demonstrated that the PtDA improved decision
quality and knowledge. A subsequent trial should follow
patients for longer than one year and repeat decisional con-
flict measures before and after surgical consultation. Find-
ings were used to inform the design and redefine primary
outcomes of a larger scale study.
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